Monitoring Therapeutic Response to Anti-Fibroblast Activation Protein (FAP) CAR T Cells using [18F]AlF-FAPI-74.
Iris K LeeEstela Noguera-OrtegaZebin XiaoLeslie ToddJohn SchollerDecheng SongMaria LiousiaKatheryn LohithKexiang XuKimberly J EdwardsMichael D FarwellCarl H JuneSteven M AlbeldaEllen PuréMark A SellmyerPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
This non-invasive imaging approach to interrogate the tumor microenvironment represents an innovative pairing of a diagnostic PET probe with solid tumor CAR T cell therapy and has the potential to serve as a predictive and pharmacodynamic response biomarker for FAP as well as other stromal cell-targeted therapies.